patritumab
amgen,daiichi sankyo
['lung']
 mentions the initial paper on patritumumab deruxtecan (her3-dxd) in her #asco22 lung cancer poster discussion 
Executive Editor of Cancer Discovery @CD_AACR, published by @AACR. @BBS_Harvard/@DanaFarber alum. Native New Yorker. Tweets are my own. She/her